HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Thierry Caus Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Caus, T. Search for Related Content PubMed Articles by Caus, T. Related Collections Transplantation - heart

Eur J Cardiothorac Surg 2006;29:863-864
© 2006 Elsevier Science NL

Letter to the Editor

Reply to Mishra

Department of Cardiac Surgery, University Hospital SUD, Avenue Salouël-Laënnec, 80000 Amiens, France

Received 25 January 2006; accepted 26 January 2006.

^_* Tel.: +33 43 22 455925; fax: +33 32 2455331. (Email: caus.thierry@chu-amiens.fr).

Key Words: MRS • Coronary circulation • Transplantation

The first 20% of the full text of this article appears below.

I thank Dr Mishra for expressing his interest in our original article [1] through his letter to the editor [2]. The structure of this letter is articulated around three points of argument. The first point is a request for additional precisions about epidemiologic data concerning both donors and recipients. Cardiac allograft vasculopathy (CAV) is mainly the consequence of post-transplant endothelial injury mediated by immunologic reactions and lacks definitive relationships with many of the usual risk factors for coronary artery disease. We therefore presented only data which were relevant for the occurrence of CAV during follow-up and, in particular, . . . [Full Text of this Article]